Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |